Invention Grant
- Patent Title: Method for assaying the activity of spermidine/spermine N1-acetyltransferase
-
Application No.: US17406956Application Date: 2021-08-19
-
Publication No.: US11441168B2Publication Date: 2022-09-13
- Inventor: Brian Cheng , Rashid Bux , Daniel Sitar
- Applicant: BioMark Technologies Inc.
- Applicant Address: CA Richmond
- Assignee: BioMark Technologies Inc.
- Current Assignee: BioMark Technologies Inc.
- Current Assignee Address: CA Richmond
- Agency: Hovey Williams LLP
- Main IPC: C12Q1/48
- IPC: C12Q1/48 ; G01N33/574

Abstract:
A method for assaying activity of the enzyme spermidine/spermine N1-acetyltransferase (SSAT) uses SSAT substrates by detecting their acetylated forms. SSAT substrates may include rimantadine and tocainide wherein their metabolism occurs in part by the action of the inducible enzyme SSAT to produce the acetylated metabolites N-acetylrimantadine and N-acetyltocainide respectively. SSAT activity may be correlated to pathologic conditions.
Public/Granted literature
- US20220033875A1 Method For Assaying The Activity Of Spermidine/Spermine N1-Acetyltransferase Public/Granted day:2022-02-03
Information query